These findings suggest that endogenous Nrf2 activity provides baseline neuroprotection against oxidative stress-induced damage, such as that seen in response to RH, ageing [26] and potentially the chronic hyperglycaemia of diabetes. The gene discussed is NFE2L2; the disease is diabetes mellitus.